A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

End-Stage Renal DiseaseType 2 Diabetes Mellitus

Interventions

DRUG

Bardoxolone Methyl 20 mg

Oral, once daily

DRUG

Placebo

Oral, once daily